A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia
Russell O Bainer,1 Matthew R Trendowski,2 Cheng Cheng,3 Deqing Pei,3 Wenjian Yang,3 Steven W Paugh,4 Kathleen H Goss,5 Andrew D Skol,6 Paul Pavlidis,7 Ching-Hon Pui,4,8 T Conrad Gilliam,1 William E Evans,4,9,* Kenan Onel10–13,* 1Department of Human Genetics, 2Department of Medicine, Sectio...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/a-p53-regulated-apoptotic-gene-signature-predicts-treatment-response-a-peer-reviewed-article-CMAR |
id |
doaj-4b8b105d438a4fbabe1c16922a5475da |
---|---|
record_format |
Article |
spelling |
doaj-4b8b105d438a4fbabe1c16922a5475da2020-11-24T23:23:20ZengDove Medical PressCancer Management and Research1179-13222017-09-01Volume 939741034710A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemiaBainer ROTrendowski MRCheng CPei DYang WPaugh SWGoss KHSkol ADPavlidis PPui CHGilliam TCEvans WEOnel KRussell O Bainer,1 Matthew R Trendowski,2 Cheng Cheng,3 Deqing Pei,3 Wenjian Yang,3 Steven W Paugh,4 Kathleen H Goss,5 Andrew D Skol,6 Paul Pavlidis,7 Ching-Hon Pui,4,8 T Conrad Gilliam,1 William E Evans,4,9,* Kenan Onel10–13,* 1Department of Human Genetics, 2Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, 3Department of Biostatistics, 4Hematological Malignancy Program, St Jude Children’s Research Hospital, Memphis, TN, 5University of Chicago Medicine Comprehensive Cancer Center, 6Department of Pediatrics, The University of Chicago, Chicago, IL, USA; 7Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; 8Department of Oncology, 9Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital, Memphis, TN, 10Division of Human Genetics and Genomics, 11Division of Hematology/Oncology and Stem Cell Transplantation, Cohen Children’s Medical Center, New Hyde Park, 12The Feinstein Institute for Medical Research, Manhasset, NY, 13Hofstra Northwell School of Medicine, Hofstra University, Hempstead, NY, USA *These authors contributed equally to this work Abstract: Gene signatures have been associated with outcome in pediatric acute lymphoblastic leukemia (ALL) and other malignancies. However, determining the molecular drivers of these expression changes remains challenging. In ALL blasts, the p53 tumor suppressor is the primary regulator of the apoptotic response to genotoxic chemotherapy, which is predictive of outcome. Consequently, we hypothesized that the normal p53-regulated apoptotic response to DNA damage would be altered in ALL and that this alteration would influence drug response and treatment outcome. To test this, we first used global expression profiling in related human B-lineage lymphoblastoid cell lines with either wild type or mutant TP53 to characterize the normal p53-mediated transcriptional response to ionizing radiation (IR) and identified 747 p53-regulated apoptotic target genes. We then sorted these genes into six temporal expression clusters (TECs) based upon differences over time in their IR-induced p53-regulated gene expression patterns, and found that one cluster (TEC1) was associated with multidrug resistance in leukemic blasts in one cohort of children with ALL and was an independent predictor of survival in two others. Therefore, by investigating p53-mediated apoptosis in vitro, we identified a gene signature significantly associated with drug resistance and treatment outcome in ALL. These results suggest that intersecting pathway-derived and clinically derived expression data may be a powerful method to discover driver gene signatures with functional and clinical implications in pediatric ALL and perhaps other cancers as well. Keywords: pediatric acute lymphoblastic leukemia, p53, gene expression signature, outcomes analysishttps://www.dovepress.com/a-p53-regulated-apoptotic-gene-signature-predicts-treatment-response-a-peer-reviewed-article-CMARPediatric acute lymphoblastic leukemiap53Gene expression signatureOutcomes analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bainer RO Trendowski MR Cheng C Pei D Yang W Paugh SW Goss KH Skol AD Pavlidis P Pui CH Gilliam TC Evans WE Onel K |
spellingShingle |
Bainer RO Trendowski MR Cheng C Pei D Yang W Paugh SW Goss KH Skol AD Pavlidis P Pui CH Gilliam TC Evans WE Onel K A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia Cancer Management and Research Pediatric acute lymphoblastic leukemia p53 Gene expression signature Outcomes analysis |
author_facet |
Bainer RO Trendowski MR Cheng C Pei D Yang W Paugh SW Goss KH Skol AD Pavlidis P Pui CH Gilliam TC Evans WE Onel K |
author_sort |
Bainer RO |
title |
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
title_short |
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
title_full |
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
title_fullStr |
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
title_full_unstemmed |
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
title_sort |
p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2017-09-01 |
description |
Russell O Bainer,1 Matthew R Trendowski,2 Cheng Cheng,3 Deqing Pei,3 Wenjian Yang,3 Steven W Paugh,4 Kathleen H Goss,5 Andrew D Skol,6 Paul Pavlidis,7 Ching-Hon Pui,4,8 T Conrad Gilliam,1 William E Evans,4,9,* Kenan Onel10–13,* 1Department of Human Genetics, 2Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, 3Department of Biostatistics, 4Hematological Malignancy Program, St Jude Children’s Research Hospital, Memphis, TN, 5University of Chicago Medicine Comprehensive Cancer Center, 6Department of Pediatrics, The University of Chicago, Chicago, IL, USA; 7Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; 8Department of Oncology, 9Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital, Memphis, TN, 10Division of Human Genetics and Genomics, 11Division of Hematology/Oncology and Stem Cell Transplantation, Cohen Children’s Medical Center, New Hyde Park, 12The Feinstein Institute for Medical Research, Manhasset, NY, 13Hofstra Northwell School of Medicine, Hofstra University, Hempstead, NY, USA *These authors contributed equally to this work Abstract: Gene signatures have been associated with outcome in pediatric acute lymphoblastic leukemia (ALL) and other malignancies. However, determining the molecular drivers of these expression changes remains challenging. In ALL blasts, the p53 tumor suppressor is the primary regulator of the apoptotic response to genotoxic chemotherapy, which is predictive of outcome. Consequently, we hypothesized that the normal p53-regulated apoptotic response to DNA damage would be altered in ALL and that this alteration would influence drug response and treatment outcome. To test this, we first used global expression profiling in related human B-lineage lymphoblastoid cell lines with either wild type or mutant TP53 to characterize the normal p53-mediated transcriptional response to ionizing radiation (IR) and identified 747 p53-regulated apoptotic target genes. We then sorted these genes into six temporal expression clusters (TECs) based upon differences over time in their IR-induced p53-regulated gene expression patterns, and found that one cluster (TEC1) was associated with multidrug resistance in leukemic blasts in one cohort of children with ALL and was an independent predictor of survival in two others. Therefore, by investigating p53-mediated apoptosis in vitro, we identified a gene signature significantly associated with drug resistance and treatment outcome in ALL. These results suggest that intersecting pathway-derived and clinically derived expression data may be a powerful method to discover driver gene signatures with functional and clinical implications in pediatric ALL and perhaps other cancers as well. Keywords: pediatric acute lymphoblastic leukemia, p53, gene expression signature, outcomes analysis |
topic |
Pediatric acute lymphoblastic leukemia p53 Gene expression signature Outcomes analysis |
url |
https://www.dovepress.com/a-p53-regulated-apoptotic-gene-signature-predicts-treatment-response-a-peer-reviewed-article-CMAR |
work_keys_str_mv |
AT bainerro ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT trendowskimr ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT chengc ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT peid ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT yangw ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT paughsw ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT gosskh ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT skolad ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT pavlidisp ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT puich ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT gilliamtc ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT evanswe ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT onelk ap53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT bainerro p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT trendowskimr p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT chengc p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT peid p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT yangw p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT paughsw p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT gosskh p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT skolad p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT pavlidisp p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT puich p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT gilliamtc p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT evanswe p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia AT onelk p53regulatedapoptoticgenesignaturepredictstreatmentresponseandoutcomeinpediatricacutelymphoblasticleukemia |
_version_ |
1725563974067421184 |